Showing Form 4 filings for CATX
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
Perspective Therapeutics, Inc.
Price
$0.84
Shares
25,000
Ownership
168,744
Value/Share
Williamson Robert F III
Dir
Unknown
Industry
41,000
178,542
Puhlmann Markus
Chief Medical Officer